Medinotec INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OQX
Medinotec reports fiscal 2026 revenue of $9.7 million, driven by international distribution growth despite U.S. market challenges.
OQX
Medinotec, Inc. announced a significant financial turnaround in its fiscal year ended February 28, 2025, reporting an 81.5% surge in revenue and a shift from a net loss to a substantial net income, primarily fueled by new distribution agreements in South Africa and successful commercialization of its Trachealator device in the United States.
OQX
Medinotec Inc. experienced a significant revenue increase in fiscal year 2024, driven by new distribution agreements and sales of its Trachealator product in the United States.